Clinical trial
Percutaneous Cryoablation of Low-risk Early Breast Cancer
NCT06300125 is registered in ClinicalTrials.gov with European Institute of Oncology as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Percutaneous Cryoablation of Low-risk Early Breast Cancer
- Lead sponsor
- European Institute of Oncology
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- April 15, 2024
- Completion date
- March 1, 2031
- Enrollment
- 234 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer